FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells

被引:1242
作者
Zhao, Jinghui
Brault, Jeffrey J.
Schild, Andreas
Cao, Peirang
Sandri, Marco
Schiaffino, Stefano
Lecker, Stewart H.
Goldberg, Alfred L. [1 ]
机构
[1] Harvard Univ, Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Renal Unit, Boston, MA 02115 USA
[3] Venetian Inst Mol Med, I-35129 Padua, Italy
[4] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy
[5] Dulbecco Telethon Inst, I-35129 Padua, Italy
[6] CNR, Inst Neurosci, I-35121 Padua, Italy
关键词
D O I
10.1016/j.cmet.2007.11.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Muscle atrophy occurs in many pathological states and results primarily from accelerated protein degradation and activation of the ubiquitin-proteasome pathway. However, the importance of lysosomes in muscle atrophy has received little attention. Activation of FoxO transcription factors is essential for the atrophy induced by denervation or fasting, and activated FoxO3 by itself causes marked atrophy of muscles and myotubes. Here, we report that FoxO3 does so by stimulating overall protein degradation and coordinately activating both lysosomal and proteasomal pathways. Surprisingly, in C2C12 myotubes, most of this increased proteolysis is mediated by lysosomes. Activated FoxO3 stimulates lysosomal proteolysis in muscle (and other cell types) by activating autophagy. FoxO3 also induces the expression of many autophagy-related genes, which are induced similarly in mouse muscles atrophying due to denervation or fasting. These studies indicate that decreased IGF-1-PI3K-Akt signaling activates autophagy not only through mTOR but also more slowly by a transcription-dependent mechanism involving FoxO3.
引用
收藏
页码:472 / 483
页数:12
相关论文
共 50 条
  • [1] The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway
    Arico, S
    Petiot, A
    Bauvy, C
    Dubbelhuis, PF
    Meijer, AJ
    Codogno, P
    Ogier-Denis, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35243 - 35246
  • [2] FoxO proteins in insulin action and metabolism
    Barthel, A
    Schmoll, D
    Unterman, TG
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (04) : 183 - 189
  • [3] Lysosomal proteolysis in skeletal muscle
    Bechet, D
    Tassa, A
    Taillandier, D
    Cornbaret, L
    Attaix, D
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (10) : 2098 - 2114
  • [4] Beehler BC, 2006, EXP BIOL MED, V231, P335
  • [5] Identification of ubiquitin ligases required for skeletal muscle atrophy
    Bodine, SC
    Latres, E
    Baumhueter, S
    Lai, VKM
    Nunez, L
    Clarke, BA
    Poueymirou, WT
    Panaro, FJ
    Na, EQ
    Dharmarajan, K
    Pan, ZQ
    Valenzuela, DM
    DeChiara, TM
    Stitt, TN
    Yancopoulos, GD
    Glass, DJ
    [J]. SCIENCE, 2001, 294 (5547) : 1704 - 1708
  • [6] Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
    Brunet, A
    Bonni, A
    Zigmond, MJ
    Lin, MZ
    Juo, P
    Hu, LS
    Anderson, MJ
    Arden, KC
    Blenis, J
    Greenberg, ME
    [J]. CELL, 1999, 96 (06) : 857 - 868
  • [7] Cuervo AM, 2000, J CELL SCI, V113, P4441
  • [8] Chaperone-mediated autophagy
    Dice, J. Fred
    [J]. AUTOPHAGY, 2007, 3 (04) : 295 - 299
  • [9] Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions
    Du, J
    Wang, XN
    Miereles, C
    Bailey, JL
    Debigare, R
    Zheng, B
    Price, SR
    Mitch, WE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (01) : 115 - 123
  • [10] FURUNO K, 1990, J BIOL CHEM, V265, P8550